Dr. Julio Delgado is a consultant haematologist at Hospital Clínic, Barcelona, researcher at IDIBAPS, and associate professor at the University of Barcelona. He is the coordinator of CART-cell trials in the institution and vice-president of the Institution’s Review Board and Ethics Committee. He is a core member of the EMA’s Scientific Advisory Group for Oncology and advisor to the Spanish Medicines Agency and Catalan Pharmacotherapy Committee.